drugset / Trial / NCT07838129

Evaluation of Corneal Endothelium Health Following Articaine Ophthalmic Solution Administration

NCT07838129 ↗

Phase 4 Not yet recruiting 165 enrolled Laboratoires Thea
RandomizedParallel-groupDouble-blindOther

Summary

The goal of this clinical trial is to evaluate the corneal endothelium health of eyes treated with articaine ophthalmic solution in adult participants.

Timeline

Start
2027-01
Primary completion
2027-12
Completion
2027-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Articaine Other / unclassified — Topical

Indications

No indication recorded.